A Beaten-Down Beer Giant With Earnings in 5 Days

One of the biggest premium beer names in the U.S. Got cut down on tariff panic. An earnings hit in five days. The dividend keeps climbing, and Mexican-import fears are already baked into the price.

June 25, 2026

You don't usually find a wide-moat staples name trading like a busted growth stock. But that's what's happened here. Investors panicked on Mexican tariff headlines, the multiple compressed, and earnings are now five days away.

Hidden Tax Breaks (Sponsored)

Capital gains taxes may quietly reduce more of your investment returns than you realize.

But the tax code includes several strategies that may help reduce that bill.

Three often-overlooked areas include investment-related expenses, cost basis adjustments, and real estate selling costs.

When structured correctly, these deductions may help minimize taxable gains.

Because the rules can be complex, many investors work with fiduciary financial advisors to plan tax-efficient strategies.

The Setup

The name is Constellation Brands (NYSE: STZ). They own Corona, Modelo, Pacifico, and a high-end wine and spirits portfolio. Modelo has been the top-selling beer in America for multiple years running. Corona Extra sits in the top five.

That's the story in one line. A category-leading staples business priced like a tariff casualty. Q1 fiscal 2027 results land on June 30, and that's the catalyst.

Why the Tariff Panic Is Overdone

Constellation imports nearly all of its beer portfolio from Mexico under USMCA. When the tariff headlines hit, the assumption was that margins would get gutted. The market punished the stock, dragging it below the midpoint of its 52-week range.

Here's what's getting missed:

  • USMCA-compliant goods have so far avoided the worst tariff scenarios floated in early 2026.

  • Constellation has pricing power. They've raised beer prices by low single digits annually for years, and depletions kept climbing.

  • Management has telegraphed that it will offset tariff costs through a mix of price, productivity, and product mix.

Strip out the noise. What you have is a beer business growing depletions in a flat-to-down U.S. Beer market. That gap between perception (tariff victim) and reality (share-taker with pricing power) is the opportunity. June 30 is the moment management gets to reset the narrative.

The Wealth Strategy (Sponsored)

His official salary? $400,000 a year.

Yet his returns point to something far bigger: Up to $250,000 per month… from just one place.

It’s not property. It’s not equities.

So what’s really generating this kind of income — and why is it gaining traction now?

The Cash Flow Story Investors Keep Forgetting

This is a cash-generative machine. Constellation has been guiding for billions in cumulative free cash flow over its current planning horizon, and management has been deploying it in three places: paying down debt taken on for the Canopy investment unwind, buying back stock, and growing the dividend.

The beer segment alone runs operating margins in the high-30% range. Best-in-class for the category. Net leverage has been ticking down, giving them more room to lean into buybacks if the stock stays depressed.

Action Item: Build a position into the June 30 print. Use any post-earnings weakness on guidance hesitancy to add. The cash-return engine doesn't care about quarterly noise.

Clean Energy (Sponsored)

The U.S. quietly labeled silver a “Critical Mineral”—but most investors haven’t noticed.

Behind the scenes, demand is rising across technology, energy, and defense… while global supply continues to tighten.

This imbalance is already pushing prices higher—and some analysts believe it’s only the beginning.

A new FREE report from Anchor Point Research breaks down what’s happening and how investors are positioning ahead of a potential surge.

The Wine and Spirits Drag Is Behind Them

Half the bear case has been the wine and spirits portfolio, which has been a millstone for two years. Management completed the divestiture of the lower-end wine brands to The Wine Group, which closed in June 2025, refocusing the company on premium-and-above.

That move strips out the lowest-margin, most volatile piece of the business. What's left is a cleaner, beer-led story. Now that the transaction is done and the business is lapping those comps, the consolidated growth and margin algorithm steps up materially. Most analysts haven't fully modeled the post-divestiture run-rate yet. That's where the re-rating fuel comes from.

The "Dogs of the Dow" strategy — buying the 10 highest-yielding stocks in the Dow — has been around for decades. Which investor popularized this simple income strategy?

Login or Subscribe to participate in polls.

Earnings Setup

Two things matter more than the headline numbers on June 30:

  • Beer depletion growth. Anything in the mid-single digits or better tells you Modelo and Pacifico are still taking share.

  • FY2027 guidance posture. If management reaffirms or nudges higher on EPS and free cash flow, the stock has room to re-rate meaningfully off a depressed base.

The bar is low. Sentiment is washed out.

The Dividend Growth Engine

STZ has been hiking the dividend at a high-single-digit clip for years. Trailing yield is around 2.3%, which doesn't sound thrilling on the surface. But the combination of payout growth, an active buyback, and a payout ratio still well below 40% tells you this dividend has a long runway.

The next hike announcement typically lands with the spring print. In the meantime, the float is shrinking via buybacks every quarter.

Action: If you want a dividend that's actually growing instead of stagnating, this is the kind of name you accumulate when sentiment is washed out. The yield-on-cost in three to five years is where the real win comes from, not the headline number today.

Outlook and Short-Term Prospects

Becton Dickinson’s Q4 2025 looks bumpy, with Diagnostics likely down 3-5% from soft academic spending, but Medical’s pharma systems and Alaris should grow 7%, per management guidance. 

Tariff impacts, a 2% profit drag, are cushioned by inventory tweaks, though pricing hikes aren’t on tap yet. China’s macro woes and value-based procurement could cut Asia sales by 4%, but Europe and U.S. hospital demand, up 5%, offset this. 

Cost controls, trimming overhead by 10%, keep margins steady at 25%. A $500 million R&D boost for connected devices signals growth, but execution missteps or funding cuts could crimp 2026 upside.

What Could Go Wrong

You have to respect the risks:

  • A genuine tariff hit on USMCA-compliant beer would compress beer-segment margins faster than price hikes can offset.

  • U.S. Beer category volumes have been soft. If macro consumer spending weakens further, premium beer takes the hit alongside everything else.

This isn't a no-brainer. It's a contrarian setup. Sizing matters. Don't load the boat into earnings. Build gradually.

Final Word

If you want a dividend stock where the market has already done the punishing for you, this is the spot. Category-leading beer brands, growing free cash flow, an active buyback, a dividend that keeps climbing, and an upcoming catalyst that could reset the narrative.

The wine divestiture is done. The business is cleaner. The beer share-gain story keeps grinding. The setup rewards patience: even if June 30 doesn't deliver an immediate re-rate, you're getting paid to wait while the beer-led model plays out.

The risk is real but bounded. STZ currently sits at roughly 12x forward earnings, historically cheap for a business of this quality.

Setup Scorecard

Entry Zone: Accumulate on weakness into the June 30 print.
Catalyst Timeline: Q1 FY2027 earnings June 30, next dividend hike expected spring 2027.
Confidence Level: Medium-High. The cash flow story and dividend growth are durable. The tariff overhang creates timing risk, but also creates the entry point.

That’s all for today’s edition of the Dividend Brief.

Thanks for reading, and if you have any feedback or dividend stocks you want me to take a look at, just reply to this email!

—Noah Zelvis
DividendBrief.com